Behavioural effects of some morphine antagonists and hallucinogens in the rat.
D000661:Amphetamine / Q000494:pharmacology*; D000700:Analgesics / Q000494:pharmacology*; D000777:Anesthetics / Q000494:pharmacology*; D000818:Animals; D001259:Ataxia / Q000139:chemically induced; D001285:Atropine / Q000494:pharmacology*; D001392:Azocines / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D003496:Cyclazocine / Q000494:pharmacology; D007977:Levallorphan / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008635:Mescaline / Q000494:pharmacology*; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced; D009269:Nalorphine / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010423:Pentazocine / Q000494:pharmacology*; D010622:Phencyclidine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D011562:Psilocybin / Q000494:pharmacology*; D011600:Psychopharmacology; D051381:Rats
D000700:Analgesics; D000777:Anesthetics; D001392:Azocines; D009292:Narcotic Antagonists; D010880:Piperidines; D011562:Psilocybin; D007977:Levallorphan; D009020:Morphine; D001285:Atropine; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D010622:Phencyclidine; D003496:Cyclazocine; D008635:Mescaline; D010423:Pentazocine; D009269:Nalorphine